Mads Hald Andersen

Professor, dr.techn., Director

Denmark

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Mads Hald Andersen is a Dr.techn. and Director at the National Center for Cancer Immune Therapy, CCIT-DK, Denmark. His research focuses on the intersection of cancer immunology and treatment resistance, with recent publications addressing topics such as T cell cancer dynamics, clonal hematopoiesis, and the modulation of tumor-associated macrophages. Professor Andersen's work contributes to understanding the tumor microenvironment and advancing targeted cancer therapies.

Articles (22)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (19)

morten gjerstorff

Professor

University of Southern Denmark

DENMARK

Mads Hald Andersen

Research Interests

Explore related searches

Contact this professor

About

Articles (22)

The antitumor activity of TGFβ-specific T cells is dependent on IL-6 signaling

A non-conditioned bone marrow transplantation mouse model to study clonal hematopoiesis and myeloid malignancies

Divergent Evolution of Malignant Subclones Maintains a Balance Between Induced Aggressiveness and Intrinsic Drug Resistance in T Cell Cancer.

Arginase-1-specific T cells target and modulate tumor-associated macrophages.

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.

Increased myeloid‐derived suppressor cell activation in clonal cytopenia of undetermined significance and low‐risk myelodysplastic syndrome

The CALR mutations enhance the expression of the immunosuppressive proteins GARP and LAP on peripheral blood lymphocytes through increased binding of activated platelets

Arginase-1 specific CD8+ T cells react toward malignant and regulatory myeloid cells

TGFβ-specific T cells induced by a TGFβ-derived immune modulatory vaccine both directly and indirectly modulate the phenotype of tumor-associated macrophages and fibroblasts

Corrigendum: <i>Ex vivo</i> modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes.

State-Of-The-Art Advancements on Cancer Vaccines and Biomarkers.

Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy

of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes

First in man study

Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms

Uncoupling CD4+ TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

Case Report: First longitudinal study of a patient with CALR positive clonal hematopoiesis of indeterminate potential developing into pre-fibrotic myelofibrosis.

Long-term follow-up of anti-PD-1 naïve patients with metastatic melanoma treated with IDO/PD-L1 targeting peptide vaccine and nivolumab

Novel immune modulatory vaccines targeting TGFβ

Novel immunotherapeutic combinations moving forward: the modulation of the immunosuppressive microenvironment

Tumor microenvironment antigens

Therapeutic cancer vaccination against mutant calreticulin in myeloproliferative neoplasms induces expansion of specific T cells in the periphery but specific T cells fail to enrich in the bone marrow

Collaborators (19)

morten gjerstorff

Lars Grøntved

Mikkel Bruhn Schuster

Belinda Guo

Simone Krebs

Nikolaj Pagh Kristensen

Luis Arnes

Özcan Met

Bo Porse

Terkild Buus

Morten Kranker Larsen

Matthew Linden

Sine Reker Hadrup

Morten Andersen

Sofia Bentivegna

Marco Donia

Inge Marie Svane

Lars Rønn Olsen

Per thor Straten

Make your next move.